REZOLUTE, INC. Payments for Purchase of Other Assets
REZOLUTE, INC. (RZLT) reported Payments for Purchase of Other Assets of $576.27 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForPurchaseOfOtherAssets1 · last filed 2015-11-16
- REZOLUTE, INC. payments for purchase of other assets for the quarter ending 2015-09-30 was $576.27K, a 242.94% increase year-over-year.
- REZOLUTE, INC. payments for purchase of other assets for the quarter ending 2015-06-30 was $2.23M, a 3091.18% increase year-over-year.
- REZOLUTE, INC. payments for purchase of other assets for the quarter ending 2015-03-31 was $608.92K.
- REZOLUTE, INC. payments for purchase of other assets for the quarter ending 2014-12-31 was $98.01K.
- REZOLUTE, INC. payments for purchase of other assets for fiscal 2015 was $3.11M, a 4341.59% increase from fiscal 2014.
- REZOLUTE, INC. payments for purchase of other assets for fiscal 2014 was $69.97K, a 497.20% increase from fiscal 2013.
- REZOLUTE, INC. payments for purchase of other assets for fiscal 2013 was $11.72K.
- REZOLUTE, INC. payments for purchase of other assets for fiscal 2011 was $0.00.
| Period end | Payments for Purchase of Other Assets 3 month | Payments for Purchase of Other Assets 6 month | Payments for Purchase of Other Assets 9 month | Payments for Purchase of Other Assets 12 month | Payments for Purchase of Other Assets 39 month | Payments for Purchase of Other Assets 42 month | Payments for Purchase of Other Assets 45 month | Payments for Purchase of Other Assets 48 month |
|---|---|---|---|---|---|---|---|---|
| 2015-09-30 | $576.27K 10-Q · filed 2015-11-16 | $2.81M derived: sum of 2 quarters · filed 2015-11-16 | $3.42M derived: sum of 3 quarters · filed 2015-11-16 | $3.52M derived: sum of 4 quarters · filed 2015-11-16 | ||||
| 2015-06-30 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-28 | $2.84M derived: sum of 2 quarters · filed 2015-09-28 | $2.94M derived: sum of 3 quarters · filed 2015-09-28 | $3.11M 10-K · filed 2015-09-28 | ||||
| 2015-03-31 | $608.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $706.92K derived: sum of 2 quarters · filed 2015-05-15 | $874.96K 10-Q · filed 2015-05-15 | $944.93K derived: sum of 4 quarters · filed 2015-11-16 | ||||
| 2014-12-31 | $98.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | $266.04K 10-Q · filed 2015-02-17 | $336.02K derived: sum of 3 quarters · filed 2015-11-16 | $336.02K derived: sum of 4 quarters · filed 2015-11-16 | ||||
| 2014-09-30 | $168.04K 10-Q · filed 2015-11-16 | $238.01K derived: sum of 2 quarters · filed 2015-11-16 | $238.01K derived: sum of 3 quarters · filed 2015-11-16 | $238.01K derived: sum of 4 quarters · filed 2015-11-16 | ||||
| 2014-06-30 | $69.97K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-28 | $69.97K derived: sum of 2 quarters · filed 2015-09-28 | $69.97K derived: sum of 3 quarters · filed 2015-09-28 | $69.97K 10-K · filed 2015-09-28 | ||||
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $0.00 derived: sum of 2 quarters · filed 2015-05-15 | $0.00 10-Q · filed 2015-05-15 | $0.00 derived: sum of 4 quarters · filed 2015-05-15 | $11.72K 10-Q · filed 2014-05-14 | |||
| 2013-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | $0.00 10-Q · filed 2015-02-17 | $0.00 derived: sum of 3 quarters · filed 2015-02-17 | $11.72K derived: sum of 4 quarters · filed 2015-02-17 | $11.72K 10-Q · filed 2014-02-13 | |||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-12 | $0.00 derived: sum of 2 quarters · filed 2014-11-12 | $11.72K derived: sum of 3 quarters · filed 2014-11-12 | $11.72K derived: sum of 4 quarters · filed 2014-11-12 | $11.72K 10-Q · filed 2013-11-12 | |||
| 2013-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30 | $11.72K derived: sum of 2 quarters · filed 2014-09-30 | $11.72K derived: sum of 3 quarters · filed 2014-09-30 | $11.72K 10-K · filed 2014-09-30 | $11.72K 10-K · filed 2013-09-11 | |||
| 2013-03-31 | $11.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-14 | $11.72K derived: sum of 2 quarters · filed 2014-05-14 | $11.72K 10-Q · filed 2014-05-14 | |||||
| 2012-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-13 | $0.00 10-Q · filed 2014-02-13 | ||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 | |||||||
| 2012-06-30 | $0.00 10-K · filed 2013-09-11 | |||||||
| 2011-12-31 | $0.00 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |